Jürgen Moll
Stevenage Bioscience Catalyst(GB)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Neuroblastoma Research and Treatments
Most-Cited Works
- → A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity(2008)213 cited
- → Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase(2010)199 cited
- → 1,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazoles: Identification of a Potent Aurora Kinase Inhibitor with a Favorable Antitumor Kinase Inhibition Profile(2006)190 cited
- → Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening(2006)179 cited
- → Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I(2008)165 cited
- → Targeting Cell Division Cycle 7 Kinase: A New Approach for Cancer Therapy(2010)122 cited
- → A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining(2008)107 cited
- → A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors(2009)93 cited
- → Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors(2010)81 cited
- → Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model(2009)67 cited